However, the studies conducted so far did not detect a reliable early biomarker, although the existing data overall suggest that I-FABP is a promising biomarker for NEC with the potential to improve its diagnostic value when combined with other markers of intestinal damage such as TFF3. Here, FABP2 is linked to necrotizing enterocolitis.